CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

January 14, 2021
Open Access

New physiological insights into the phenomena of deer antler: A unique model for skeletal tissue regeneration

Journal of Orthopaedic Translation
Mesalie FelekeJiake Xu
January 14, 2021
Open Access

Narrative review of the choices of stem cell sources and hydrogels for cartilage tissue engineering

Annals of Translational Medicine
Zhantao DengQiujian Zheng
January 11, 2021

Synthetic biology in biofilms: Tools, challenges, and opportunities

Biotechnology Progress
Peter Tran, Arthur Prindle
January 9, 2021
Open Access

Precision regenerative medicine

Stem Cell Research & Therapy
Amy L Lightner, Timothy Chan
January 15, 2021
Open Access

Parallel functional testing identifies enhancers active in early postnatal mouse brain

BioRxiv : the Preprint Server for Biology
J. T. LambertAlex S Nord
January 10, 2021
Open Access

Biological Characteristics and Osteogenic Differentiation of Ovine Bone Marrow Derived Mesenchymal Stem Cells Stimulated with FGF-2 and BMP-2

International Journal of Molecular Sciences
Sandra GromolakAleksandra Klimczak
January 16, 2021
Open Access

Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time

Journal of Clinical and Translational Hepatology
Mithun SharmaDuvurr Nageshwar Reddy
January 16, 2021

Preimplantation Genetic Testing for Aneuploidy - a Castle Built on Sand

Trends in Molecular Medicine
Norbert GleicherAli Brivanlou
January 17, 2021

A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Iris de WeerdtHans J van der Vliet
January 15, 2021
Open Access

Large-scale genetic association and single cell accessible chromatin mapping defines cell type-specific mechanisms of type 1 diabetes risk

BioRxiv : the Preprint Server for Biology
J. ChiouKyle J Gaulton
January 13, 2021

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients with Cardiometabolic Disease

Circulation. Genomic and Precision Medicine
Nicholas A MarstonChristian T Ruff
January 12, 2021
Open Access

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants

Stem Cells International
Shujun LinTianbiao Zhou
January 15, 2021
Open Access

The Immune-Modulatory Properties of iPSC-Derived Antigen-Presenting Cells

Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie
Mania AckermannNico Lachmann
January 10, 2021

Use of Cryopreserved Human Amniotic Membrane in the treatment of skin ulcers secondary to calciphylaxis

Dermatologic Therapy
J A López MartínezC J Fernández Pascual

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

© 2021 Meta ULC. All rights reserved